Amniotic membrane patch shows promise for stubborn diabetic wounds

NCT ID NCT06565156

Completed Disease control Sponsor: BioStem Technologies Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Aug 13, 2026 · Updated 2 times

Summary

This study tests whether adding a special amniotic membrane graft (BR-AM) to standard wound care helps heal diabetic foot ulcers better than standard care alone. About 72 adults with non-infected, non-healing ulcers will be randomly assigned to receive either BR-AM plus standard care or standard care only. The main goal is to see if more wounds close completely within 12 weeks.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: BR-AM (amniotic membrane allograft)
What this could lead to: If successful, this could provide a new treatment option to help heal diabetic foot ulcers faster and reduce complications.
What could go wrong: This is a small, early-stage trial with only 72 participants. The treatment may not prove more effective than standard care, and results may not apply to all patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DIABETIC FOOT are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Diabetic Foot

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

DIABETIC FOOT DIABETIC FOOT ULCER DIABETIC WOUND NON-INFECTED DIABETIC FOOT ULCER NON-ISCHEMIC DIABETIC FOOT ULCER

Contacts and locations

Locations

Site 01

Vista, California, 92081, United States
Site 02

San Francisco, California, 94115, United States
Site 15

Chapel Hill, North Carolina, 27599, United States
Site 16

Lake Success, New York, 11042, United States
Site 17

Guntersville, Alabama, 35976, United States
Site 18

Boston, Massachusetts, 02118, United States
Site 19

Palmdale, California, 93551, United States
Site 20

Deerfield Beach, Florida, 33442, United States
Site 21

Burleson, Texas, 76028, United States
Site 22

Mesa, Arizona, 85206, United States
Site 23

Springfield, Illinois, 62704, United States
Site 24

San Antonio, Texas, 78229, United States
Site 25

Tucson, Arizona, 85723, United States
Site 26

Detroit, Michigan, 48201, United States
Site 27

Coral Gables, Florida, 33134, United States
Site 28

DeLand, Florida, 32720, United States
Site 29

Brownsville, Texas, 78520, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.